COMMODORE CAPITAL LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Ambrx Biopharma Inc. | April 27, 2023 | 31,181,983 | 8.1% |
BELLUS Health Inc. | March 30, 2023 | 6,579,359 | 5.2% |
IMARA Inc. | February 21, 2023 | 2,840,754 | 10.8% |
Karyopharm Therapeutics Inc. | February 14, 2023 | 1,935,609 | 1.7% |
VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Satsuma Pharmaceuticals, Inc.Sold out | November 16, 2022 | 0 | 0.0% |
GENOCEA BIOSCIENCES, INC. | February 14, 2022 | 3,079,756 | 5.4% |